Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-08-01

Clinical Trial Update: Microscopic Fluorescence-guided Vestibular Schwannoma Resection Using Fluorescein Sodium and YELLOW 560 [Phase 2]

View source ↗

Summary

Phase 2 trial update for microscopic fluorescence-guided resection of vestibular schwannoma using fluorescein sodium and YELLOW 560 completed with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluorescein Sodium (fluorescein sodium)
  • YELLOW 560

Snippet

Sponsor: Mayo Clinic | Conditions: Vestibular Schwannoma | Phase 2 | Status: COMPLETED | Results posted: 2023-08-01